We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current LPTX market cap is 114.95M. The company's latest EPS is USD -2.1247 and P/E is -1.39.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.83M | -14.82M | -14.83M | -21.25M | -17.86M |
| Net Income | -13.7M | -12.47M | -13.82M | -20.13M | -18.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.5M | 1.5M | 0 | 0 |
| Operating Income | -33.45M | -28.54M | -41.43M | -56.76M | -87.04M |
| Net Income | -33.26M | -37.59M | -40.59M | -54.6M | -81.41M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 83.05M | 72.83M | 57.96M | 81.43M | 65.05M |
| Total Liabilities | 11.04M | 12.68M | 10.59M | 15.64M | 16.09M |
| Total Equity | 72.01M | 60.14M | 47.37M | 65.79M | 48.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.45M | 54.37M | 117.91M | 70.35M | 72.83M |
| Total Liabilities | 9.2M | 7.72M | 10.02M | 11.49M | 12.68M |
| Total Equity | -1.75M | 46.65M | 107.89M | 58.87M | 60.14M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.37M | -43.75M | -15.52M | -29.19M | -44.79M |
| Investing | 48.97M | 48.97M | N/A | N/A | N/A |
| Financing | -30k | -30k | 29k | 37.15M | 37.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.9M | -25.96M | -35.16M | -49.04M | -43.75M |
| Investing | -85k | 25k | N/A | N/A | 48.97M |
| Financing | 14.82M | 74M | 98.04M | -210k | -30k |
| Market Cap | 114.95M |
| Price to Earnings Ratio | -1.39 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.6 |
| Price to Book Ratio | 1.88 |
| Dividend Yield | - |
| Shares Outstanding | 38.32M |
| Average Volume (1 week) | 160.21k |
| Average Volume (1 Month) | 398.44k |
| 52 Week Change | -25.56% |
| 52 Week High | 5.00 |
| 52 Week Low | 1.68 |
| Spread (Intraday) | 0.53 (15.63%) |
| Company Name | Leap Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.leaptx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
